MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0347056

Медицинская библиотека · PloS one · 2026

Validating the 2-minute walk test MCID for subacute stroke patients: A Pakistani multicenter cohort analysis.

Khan Muslim, Muzamil Hafiz Shehzad, Osailan Ahmad M, Alhammad Ayman Abdullah, Khan Samiullah, Mushtaq Mazhar, Moustafa Engy BadrEldin Saleh, Alsalem Theeb Naif S, Muteesasira Edward

СтатьяМногоцентровое исследованиеВалидационное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The 2-Minute Walk Test (2MWT) is a simple and reliable test used by clinicians to evaluate mobility gains in stroke populations.

OBJECTIVE

To determine the minimally clinically important difference (MCID) for the 2-Minute Walk Test (2MWT) in subacute stroke populations.

DESIGN

This was a prospective cohort study.

SETTING

The study was carried out across seven rehabilitation centers in Pakistan.

PARTICIPANTS

150 adults (<180 days post-stroke),with a confirmed ischemic or hemorrhagic stroke, able to walk at least 10 meters, and Mini-Mental State Examination score ≥24.

INTERVENTIONS: Participants underwent 6-8 weeks of standard rehabilitation, including physical therapy (gait and balance training) and, in some centers, robotic gait training. Interventions varied by center but followed standardized gait and balance goals.

MAIN OUTCOME MEASURES: The 2MWT was the primary outcome measure whereas, the Activities-specific Balance Confidence gait subscale (ABC_Gait), Global Perceived Effect (GPE) scale, and Modified Barthel Index (MBI) were the secondary outcome measures. The MCID was estimated using an anchor-based approach (ABC_Gait ≥10% improvement), validated by distribution-based methods.

RESULTS

The 2MWT MCID was 33 meters (95% CI: 30-36 meters), with 87% sensitivity and 82% specificity. A strong correlation was observed between 2MWT and ABC_Gait change scores (r = 0.68, p < 0.001). The mean 2MWT distance improved from 62.5 ± 38.4 meters to 98.7 ± 42.1 meters (p < 0.001). Subgroup analyses showed that MCID was consistent across age groups, stroke types, and intervention modalities.

CONCLUSION

The 33 meters MCID for the 2MWT is a reliable and patient-centered benchmark for assessing mobility gains in subacute stroke populations. Validation in chronic stroke populations and exploration of emerging interventions like virtual reality (VR) is needed to extend the 2MWT MCID's applicability.

Для цитирования: Khan Muslim, Muzamil Hafiz Shehzad, Osailan Ahmad M, Alhammad Ayman Abdullah, Khan Samiullah, Mushtaq Mazhar, Moustafa Engy BadrEldin Saleh, Alsalem Theeb Naif S, Muteesasira Edward. Validating the 2-minute walk test MCID for subacute stroke patients: A Pakistani multicenter cohort analysis.. PloS one. 2026. DOI: 10.1371/journal.pone.0347056.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.